Global Diabetes Management Devices Market Growth (Status and Outlook) 2024-2030

Global Diabetes Management Devices Market Growth (Status and Outlook) 2024-2030

Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.

The global Diabetes Management Devices market size is projected to grow from US$ 39160 million in 2023 to US$ 63970 million in 2030; it is expected to grow at a CAGR of 7.3% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Diabetes Management Devices Industry Forecast” looks at past sales and reviews total world Diabetes Management Devices sales in 2023, providing a comprehensive analysis by region and market sector of projected Diabetes Management Devices sales for 2024 through 2030. With Diabetes Management Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Management Devices industry.

This Insight Report provides a comprehensive analysis of the global Diabetes Management Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetes Management Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Management Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Management Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Management Devices.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Management Devices market by product type, application, key players and key regions and countries.

Segmentation by type
Blood Glucose Monitoring Device
Insulin Delivery Systems

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Dexcom
Roche
Lifescan
Medtronic
Terumo
B. Braun Melsungen
BD
Ascensia (Bayer)
Senseonics Holdings
Johnson & Johnson
Eli Lilly
Novo Nordisk
Sanofi
Ypsomed Holding
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
All Medicus

Please note: The report will take approximately 2 business days to prepare and deliver.